In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade
- PMID: 11250947
- DOI: 10.1210/endo.142.4.8084
In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade
Abstract
Human central nervous system tumors and glioma cell lines highly express the insulin-like growth factor-binding protein (IGFBP)-2. As IGFBP-2 can affect tumor growth, we studied the relationship between IGFBP-2 expression and the malignancy of brain tumors in vivo. To do so, we investigated by immunohistochemistry the accumulation of IGFBP-1, -2, and -3 in 50 human gliomas classified by the WHO Malignancy Scale. Double labeling using anti-CD68 (monocytes/macrophages), antiglial fibrillary acidic protein, and anti-CD3 (T cells) antibodies was performed to further characterize the IGFBP-1, -2, and -3(+) cells. The expression of IGFBP messenger RNAs (mRNAs) was tested by RT-PCR in tumor samples from nine gliomas of different grades and in eight cell lines representing the cellular composition of human glioma. As controls, the accumulation of IGFBP-2 was investigated in normal brain and in the rat C6 glioblastoma model. IGFBP-1 and -3 accumulated in endothelial and macrophage/microglial cells. IGFBP-2(+) macrophage/microglial and glioma cells clustered in the immediate vicinity of focal necrosis of the human gliomas as well as of the rat C6 glioblastoma. The labeling score of IGFBP-1 accumulation in endothelial cells correlated negatively (P: = 0.0229), and that of IGFBP-2 accumulation in glioma cells correlated positively (P: < 0.0006) with the tumor grade of the gliomas. In addition, RT-PCR analysis confirmed mRNA expression of IGFBP-1, -2, and -3 by the gliomas and glial cells. Small amounts of IGFBP-1 and -3 mRNA, but high amounts of IGFBP-2 mRNA, were detectable in macrophage-like and glioma cell lines. The results suggest cell type-specific accumulation of IGFBP-1, -2, and -3 in human glial tumors of the brain. The increase in IGFBP-2 expression with this malignancy suggests a role of IGFBP-2 in the biology of human gliomas.
Similar articles
-
Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1399-408. doi: 10.1158/1055-9965.EPI-09-1213. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501753
-
STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.J Neurosurg. 2014 Aug;121(2):374-83. doi: 10.3171/2014.4.JNS131198. Epub 2014 May 30. J Neurosurg. 2014. PMID: 24878287
-
Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.Virchows Arch. 2008 Dec;453(6):599-609. doi: 10.1007/s00428-008-0685-7. Epub 2008 Oct 25. Virchows Arch. 2008. PMID: 18953566
-
The role of fibroblast growth factors and their receptors in gliomas: the mutations involved.Rev Neurosci. 2019 Jul 26;30(5):543-554. doi: 10.1515/revneuro-2018-0051. Rev Neurosci. 2019. PMID: 30379640 Review.
-
Transforming growth factor-beta and its implication in the malignancy of gliomas.Target Oncol. 2015 Mar;10(1):1-14. doi: 10.1007/s11523-014-0308-y. Epub 2014 Mar 5. Target Oncol. 2015. PMID: 24590691 Review.
Cited by
-
Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm.Brain Pathol. 2002 Jan;12(1):87-94. doi: 10.1111/j.1750-3639.2002.tb00425.x. Brain Pathol. 2002. PMID: 11770904 Free PMC article. Review.
-
Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.PLoS One. 2012;7(10):e46851. doi: 10.1371/journal.pone.0046851. Epub 2012 Oct 11. PLoS One. 2012. PMID: 23071652 Free PMC article.
-
A Molecular Predictor Reassesses Classification of Human Grade II/III Gliomas.PLoS One. 2013 Jun 21;8(6):e66574. doi: 10.1371/journal.pone.0066574. Print 2013. PLoS One. 2013. PMID: 23805239 Free PMC article. Clinical Trial.
-
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.Neuro Oncol. 2009 Oct;11(5):468-76. doi: 10.1215/15228517-2008-114. Epub 2009 Jan 22. Neuro Oncol. 2009. PMID: 19164435 Free PMC article.
-
Effects of Lacticaseibacillus rhamnosus HA-114 probiotic supplementation on circulating IGFBP-2 levels during a calorie-restricted diet in overweight humans.J Clin Transl Endocrinol. 2024 Jun 11;36:100357. doi: 10.1016/j.jcte.2024.100357. eCollection 2024 Jun. J Clin Transl Endocrinol. 2024. PMID: 38948244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous